All Posts by

Amanda Reifenrath

SCIRC Researcher Awarded U.S. Patent for Novel Therapeutic Strategy

A researcher affiliated with the University of Florida’s Sepsis and Critical Illness Research Center (SCIRC) has been awarded a U.S. patent for a novel therapeutic approach targeting key metabolic pathways involved in disease progression. The patent, titled “Polypeptide Inhibitor of De Novo Lipogenesis in Cancer Cells,” was issued…